Search tips
ECCMID 2023
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
13 May 2014 - P1727
Penetration of colistin into central nervous system in critically ill patients with proven or suspected central nervous system infections
Sonia Luque, Luque, S.(1)*; Sorli, L.(2); Alvarez-Lerma, F.(3); Campillo, N.(1); Basas, M.(3); Horcajada, J.P.(2); Knobel, H.(2); Montero, M.(2); Salas, E.(1); Grau, S.(1);
13 May 2014 - P1728
Pharmacokinetics of colistin methanesulfonate (CMS) in burns patients
Lorena Baietto, Baietto, L.(1)*; D'Avolio, A.(1); Corcione, S.(1); Malvasio, V.(2); Di Perri, G.(1); Stella, M.(2); De Rosa, F.G.(1);
13 May 2014 - P1729
Tissue exposure kinetics of colistin sulfate in a neutropenic mouse thigh model
Renu Singh, Singh, R.(1)*; Farrington, K.(1); Sathe, A.(2); Gupta, A.(2); Hale, M.(3); Kern, G.(1);
13 May 2014 - P1730
Polymyxin B: can we create a better product?
Zahra Kassamali, Kassamali, Z.(1)*; Rhomberg, P.R.(2); Jones, R.N.(3); Danziger, L.H.(4); Prince, R.A.(5);
13 May 2014 - P1731
Methionine ameliorates polymyxin-induced nephrotoxicity in mice
Jian Li, Wang, J.(1); Azad, M.A.K.(1); Nation, R.L.(1); Roberts, K.D.(2); Thompson, P.E.(2); Velkov, T.(1); Li, J.(1)*;
13 May 2014 - P1732
Predictors of fluoroquinolone resistance in Pseudomonas aeruginosa: area under the curve related to either MIC or the mutant prevention concentration
Alexander A. Firsov, Strukova, E.(1)*; Shlykova, D.(1); Portnoy, Y.(1); Zinner, S.(2); Firsov, A.(1);
13 May 2014 - P1733
Use of cefepime against P. aeruginosa in a murine pneumonia model
George Drusano, Drusano, G.(1)*; Liu, W.(1); Fikes, S.(1); Robbins, N.(1); Kurhanewicz, S.(1); Rodriguez, J.(1); Baluya, D.(1); Louie, A.(1);
13 May 2014 - P1734
Post-antibiotic effect (PAE) and post-beta-lactamase-inhibitor effect (PLIE) of ceftazidime, ceftaroline and aztreonam, alone and in combination with avibactam against target Gram-negative organisms with extended-spectrum beta-lactamases
Dean Shinabarger, Pillar, C.M.(1)*; Stoneburner, A.(1); Shinabarger, D.L.(1); Krause, K.(2); Nichols, W.W.(3);
13 May 2014 - P1735
In vivo pharmacodynamics of ceftolozane against Streptococcus pneumoniae and Pseudomonas aeruginosa across a wide range of MICs in a neutropenic murine thigh infection model
David Andes, Andes, D.(1)*; Alex, L.(1);
13 May 2014 - P1736
Pharmacodynamics of tazobactam combined with cefepime in a neutropenic mouse thigh model
Ria Melchers, Melchers, M.J.(1)*; van Mil, A.C.(1); Lagarde, C.(1); Mouton, J.W.(1);
13 May 2014 - P1737
Phase I, randomised single- and multiple-dose study of ceftaroline fosamil 600 mg every 12 h (60-min infusion) and every 8 h (120-min infusion)
Mark Waterlow, Sunzel, M.(1)*; Kujacic, M.(2); Broadhurst, H.(3); Li, J.(1); Edeki, T.(1);
13 May 2014 - P1738
Pharmacodynamic profiling of intravenous beta-lactams against Gram-negative isolates from bloodstream infections from a Brazilian hospital
Leandro Cardinal, Cardinal, L.S.M.(1)*; Macedo, R.S.(1); Cabral, L.G.(1); Meneses, J.P.(1); Monteiro, V.G.(2); Neto, P.A.M.(3); Araújo, M.R.E.(3); Duarte, A.S.(3); Furtado, G.H.(2);
13 May 2014 - P1739
In treatment of Pseudomonas aeruginosa with piperacillin tazobactam, addition of low dose gentamicin markedly reduces emergence of resistance and increases antibacterial effect
Alexandra Cochrane, Cochrane, A.(1)*; Bowker, K.(2); Noel, A.(2); MacGowan, A.(2);
13 May 2014 - P1740
Exploring PK/PD relationship of a novel beta-lactamase inhibitor MK-7655 in combination with imipenem in a hollow fibre infection model
Jin Wu, Wu, J.(1)*; Racine, F.(2); Rizk, M.L.(3); Wismer, M.K.(4); Harradine, P.(5); Young, K.(2); Motyl, M.(2);
13 May 2014 - P1741
Protein binding of ertapenem in plasma from healthy volunteers and from ICU patients
Frieder Kees, Kratzer, A.(1); Liebchen, U.(2); Wicha, S.G.(3); Kees, F.(4)*; Kees, M.G.(5);
13 May 2014 - P1742
Population pharmacokinetic and pharmacodynamic analysis of metronidazole in Japanese patients with intra-abdominal infections and pelvic inflammatory disease
Nobuko Takenaka, Takenaka, N.(1)*; Shoji, S.(1); Tomono, Y.(1);
13 May 2014 - P1743
Pharmacokinetic-pharmacodynamic (PK-PD) target attainment (TA) analyses supporting the selection of in vitro susceptibility test interpretive criteria for ceftolozane/tazobactam (TOL/TAZ) against Pseudomonas aeruginosa
Paul Ambrose, Melhem, M.(1); Forrest, A.(1); Rubino, C.(1); Bhavnani, S.(1); Steenbergen, J.(2); Krishna, G.(2); Ambrose, P.(1)*;
13 May 2014 - P1744
Monte Carlo simulation to evaluate the probability of attaining targeted pharmacodynamic exposure of ceftaroline fosamil against pathogens associated with CAP and SSTI in Europe
Alicia Rodríguez-Gascón, Rodríguez-Gascón, A.(1)*; Isla, A.(1); Canut, A.(2);
13 May 2014 - P1745
Pharmacokinetic/pharmacodynamic analysis of moxifloxacin in patients with diabetic foot infections
Sebastian Wicha, Wicha, S.G.(1)*; Zink, K.(2); Haak, T(2); Kees, F.(3); Kloft, C.(1); Kees, M.G.(4);
13 May 2014 - P1746
Use of Bayesian pharmacokinetic models to predict meropenem concentrations in critically ill patients – application to therapeutic drug monitoring
Jaime Esteban-Moreno, Farkas, A.(1); Wong, G.(2); Daroczi, G.(3); Lipman, J.(2); Roberts, J.(2)*;
Loading ...
+ load more
FAQ
To access content in the eLibrary you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ECCMID where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.